KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Intangibles: 2012-2024

Historic Change in Intangibles for Travere Therapeutics (TVTX) over the last 13 years, with Dec 2024 value amounting to $36.2 million.

  • Travere Therapeutics' Change in Intangibles rose 83.69% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.6 million, marking a year-over-year increase of 51.40%. This contributed to the annual value of $36.2 million for FY2024, which is 12.93% down from last year.
  • Per Travere Therapeutics' latest filing, its Change in Intangibles stood at $36.2 million for FY2024, which was down 12.93% from $41.6 million recorded in FY2023.
  • In the past 5 years, Travere Therapeutics' Change in Intangibles registered a high of $41.6 million during FY2023, and its lowest value of $17.8 million during FY2020.
  • Moreover, its 3-year median value for Change in Intangibles was $36.2 million (2024), whereas its average is $35.4 million.
  • Per our database at Business Quant, Travere Therapeutics' Change in Intangibles skyrocketed by 48.90% in 2022 and then declined by 12.93% in 2024.
  • Over the past 5 years, Travere Therapeutics' Change in Intangibles (Yearly) stood at $17.8 million in 2020, then increased by 7.03% to $19.1 million in 2021, then surged by 48.90% to $28.4 million in 2022, then spiked by 46.62% to $41.6 million in 2023, then declined by 12.93% to $36.2 million in 2024.